CoChat

Inhibition of T cell–dependent and RANKL‐dependent osteoclastogenic processes associated with high levels of bone mass in interleukin‐15 receptor–deficient mice

Open access
Djaafar, Souad, Pierroz, Dominique D., Chicheportiche, Rachel, Zheng, Xin Xiao, Ferrari, Serge L., Ferrari‐Lacraz, Sylvie · 2010 · Arthritis & Rheumatism
Cited by 61

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objective: T cell production of RANKL, interferon‐γ (IFNγ), and other cytokines in inflammatory processes such as rheumatoid arthritis or secondary to conditions such as estrogen deficiency stimulates osteoclast activity, which leads to bone resorption and bone loss. The purpose of this study was to characterize the effects of interleukin‐15 (IL‐15), a master T cell growth factor whose role in bone remodeling remains unknown. Methods: We used mice lacking the IL‐15 receptor (IL‐15Rα−/−) to investigate the effects of IL‐15 on osteoclast development, T cell and dendritic cell activation in vitro and in vivo, bone mass, and microarchitecture in intact and ovariectomized (OVX) mice. Results: In wild‐type (WT) animals, IL‐15 and RANKL provided a costimulatory signal for osteoclast development. Spleens from IL‐15Rα−/− mice contained few c‐Kit+ osteoclast precursors, and the expression of NF‐ATc1 and the osteoclastogenic response to RANKL were impaired. In addition, dendritic cell–dependent and T cell–dependent mechanisms of osteoclast activation, including RANKL and IFNγ production, were impaired in IL‐15Rα−/− mice. In turn, IL‐15Rα−/− T cells failed to stimulate WT osteoclasts, whereas WT T cells failed to stimulate IL‐15Rα−/− osteoclasts. Compared with WT mice, both intact and OVX IL‐15Rα−/− mice had significantly greater bone mineral density and microarchitecture, including a higher trabecular bone volume fraction and cortical thickness. The numbers of osteoclasts on the bone surface as well as markers of bone turnover were significantly decreased in IL‐15Rα−/− mice. Conclusion: In the absence of IL‐15 signaling, several converging mechanisms of osteoclastogenesis are inhibited, both directly and indirectly, through T cells, which leads to a high bone mass phenotype. Targeting the IL‐15 pathway may represent a novel therapeutic approach to treating primary and secondary osteoporosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.27645

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Djaafar, S., Pierroz, D. D., Chicheportiche, R., Zheng, X. X., Ferrari, S. L., & Ferrari‐Lacraz, S.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2010-10-29
Volume
62
Issue
11
Pages
3300-3310
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2070845911
Cited by
61
References
8
FWCI
2.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.